top of page
Blue Skies

World's Only Cloud Lab, HTE, & Lab Automation Virtual Conference 2023

Dates: December 5-6, 2023

Start Time: 10 a.m. ET / 7 a.m. PT

We are bringing together the relevant individuals and organizations for the 3rd Annual Cloud Lab, High Throughput Experimentation, and Lab Automation Conference.

We are pivoting the typical conference approach by reducing the tracks and bringing the most interesting talks with a better attendee experience.

 

  • Daily round table summaries

  • Keynotes

  • Industry and academic speakers

  • Sponsorship levels to meet your budget

  • Optional virtual Vendor Showcase booth

Event Sponsors

ACD/Labs
LabVoice logo
Strateos Logo
Virscidian logo
Revvity Signals
Monomer Bio
XavoLogo
StableBody Tech Logo
BASF
AstraZeneca
Artitificial logo
Takeda
Arctoris
Singh Instruments Logo.jpeg
Sila
Agenda Tuesday, December 5th
Agenda Tuesday, December 5th

Event Speakers

Chris Stumpf Teams Profile

Chris Stumpf, PhD

Senior Principal Marketing Professional

Revvity Signals

WORLDWIDE

Talk Title:

Accelerating Scientific Data Capture, Improving Data Management and Analysis with a Comprehensive Digital Research Platform

Abstract:

How does a potential hit compound evolve into a lead and then a potential drug candidate? In the pursuit of successful drug candidates, many are made and must be tested throughout the discovery, clinical and regulatory approval stages. The development of a novel drug candidate requires engagement of various scientific expertise domains including chemistry, biology, bioinformatics, pharmacology and ADME/PK. Often these domain experts work in disparate locations or even disparate companies. This presentation will illustrate how using a comprehensive digital research platform, Signals Research Suite, enables researchers across scientific domains and geographies to collaborate better and manage the entire Make-Test-Decide R&D life cycle. Our presentation will cover how Signals Research Suite can help facilitate lead optimization to drug candidate triage, with Signals Notebook (Make); content data capture and collaboration with Signals Vitro Vivo (Test); and results – data-driven scientific decisions with Signals Inventa (Decide), all within a single platform.

Nikki Dare_ACD Labs

Nikki Dare, PhD

Katalyst D2D Product Manager

ACD/Labs

WORLDWIDE

Talk Title:

Case Studies: Improving Experiment Design and Automation of Analytical Data Processing and Management in HTE

Abstract:

Automation and high throughput synthesis (more generally referred to as High Throughput Experimentation—HTE) with the help of robotics has allowed scientists to significantly increase experiment output and, subsequently, the amount of analytical data collected, in shorter periods of time. Many solutions for managing HT experiments require the use of multiple software systems, as well as transfer of data between these systems. We will present how purpose-built HTE software is being used to facilitate experiment design and automated targeted analytical data processing for different HTE workflows.

Zev Wisotsky, PhD_Headshot

Zev Wisotsky, PhD

Senior Principal Marketing Manager

Revvity Signals

WORLDWIDE

Talk Title:

Accelerating Scientific Data Capture, Improving Data Management and Analysis with a Comprehensive Digital Research Platform

Abstract:

How does a potential hit compound evolve into a lead and then a potential drug candidate? In the pursuit of successful drug candidates, many are made and must be tested throughout the discovery, clinical and regulatory approval stages. The development of a novel drug candidate requires engagement of various scientific expertise domains including chemistry, biology, bioinformatics, pharmacology and ADME/PK. Often these domain experts work in disparate locations or even disparate companies. This presentation will illustrate how using a comprehensive digital research platform, Signals Research Suite, enables researchers across scientific domains and geographies to collaborate better and manage the entire Make-Test-Decide R&D life cycle. Our presentation will cover how Signals Research Suite can help facilitate lead optimization to drug candidate triage, with Signals Notebook (Make); content data capture and collaboration with Signals Vitro Vivo (Test); and results – data-driven scientific decisions with Signals Inventa (Decide), all within a single platform.

Dan Rines_Headshot

Dan Rines, PhD

VP Technology Enabling & Digital Transformation Services

Strateos

WORLDWIDE

Talk Title:

Leveraging Wet Lab Automation in Integrated End-to-End Drug Discovery

Abstract:

In this presentation, we will explore the transformative potential of leveraging wet lab automation in drug discovery. Pioneered by companies like Strateos and Arctoris, developing integrated, automated drug discovery processes on demand is a paradigm shift for the biotech and pharma industry.

 

The talk will explore the development and evolution of Strateos’ platform, software, and process capabilities, as well as the development and evolution of Arctoris’ Ulysses platform. The unique potential of integrated wet lab automation will come to life with case studies and practical examples highlighting successful use cases accelerating both small molecule and biologics discovery.

 

Finally, the talk will also present a view towards the future, including current trends, on-going developments, and partnerships on the horizon.

John Walzer_Headshot

John Walzer, PhD

Scientific Advisor

Singh Instruments

WORLDWIDE

Talk Title:

Expanding the Process Parameter Space for High Throughput Screening in Chemistry

Abstract:

Mark Spears_Headshot

Mark Spears, PhD

Senior Scientist

Virscidian Inc.

WORLDWIDE

Talk Title:

Streamlined Design to Results with the Analytical Studio Platform

Abstract:

An integrated and automated approach to high-throughput experimentation (HTE) has been an industry goal for many years. The presentation will highlight how Virscidian’s Analytical Studio platform is directly addressing these challenges. With modern API’s, an open data approach, and excellent tools both for experimental design and data processing, this goal is within reach. In particular, Virscidian’s new Experiment Builder application adds a critical piece in this workflow, allowing scientists to design their plates and automate much of the sample analysis.

Florian Tauchert_Headshot

Florian Tauchert

VP of Engineering

Xavo

WORLDWIDE

Talk Title:Navigating Lab Disruptions: A story of Lab Ops Scheduling Success

Abstract:

In this presentation, we illuminate a critical challenge faced by laboratories in the pharmaceutical R&D domain—a scheduling problem exacerbated by unforeseen hardware failure. Delving into a case study from a client, we navigate through the chaos that ensued when a high-throughput automated store malfunctioned for several days, leading to a backlog of orders. Our focus lies on the transformative role of our scheduling system in mitigating this crisis. By orchestrating the prioritization of tasks, preventing parallel bookings of shared resources, and offering foresight into upcoming schedules, the scheduling solution emerged as the main contributor for restoring order. Join us as we dissect this real-world scenario, underscoring the indispensable nature of advanced scheduling methodologies in the face of operational disruptions.

Harry Horn_StableBody_Headshot

Harry Horn, PhD

Co-Founder, CEO, & COO

StableBody Tech

WORLDWIDE

Talk Title:

The Impact of BioDesign on BioManufacturing

Abstract:

StableBody Technologies LLC, is revolutionizing the bio-processing industry with their proprietary “Universal Rational Protein BioDesign Using Proprietary Thermodynamic Stabilization of Proteins”. This innovative technology utilizes unique and powerful algorithms to generate amino acid sequences for structurally and functionally improved antibody protein products (Cold Chain Free™). With the introduction of AffiBio-UIA™, scientists have access to this cutting-edge technology, providing greater control over the design process while significantly reducing development and processing time and cost.

Nikhita Singh_Headshot

Nikhita Singh, PhD

Co-Founder, CPO & Board Member

Artificial, Inc.

WORLDWIDE

Talk Title:

Empowering Biotech Innovation: Enabling Closed-Loop Labs with Artificial's Orchestration Platform

Abstract:

This talk will explore how Artificial's platform reshapes the traditional lab environment—transitioning from manual, error-prone processes to a seamlessly integrated, closed-loop system. Attendees will gain insights into how the platform's key features, such as digital twins, interactive SOPs, and flexible workflow tools, enable more efficient, accurate, and scalable lab operations. By leveraging Artificial's unique capabilities, including its powerful LabOps and extensive suite of adaptors, biotech labs can achieve unprecedented levels of data accuracy, operational efficiency, and experiment repeatability.

Kelcy Newell_Headshot

Kelcy Newell, PhD

Sr. Director, Robotics & Automation Development

AstraZeneca

WORLDWIDE

Talk Title:

Lab Automation & Robotics "Chalk Talk"

Sam Berg

Sam Alberg

Account Executive

Monomer Bio

WORLDWIDE

Talk Title:

Stem Cell Culture Automation in Support of Your Drug Development Pipeline

Abstract:

Join Monomer Bio for a presentation on stem cell culture automation and the creation of novel, iPSC-derived disease models. Monomer will discuss their unique approach to lab automation software and review their data-centric solutions for automated cell culture. This presentation will include a live demonstration of the Monomer software platform and a discussion of the impacts of stem cell culture automation on our customer's drug development pipelines.

Adrian Ramirez_Heashot

Adrian Galilea, PhD

Senior Lab Automation Scientist

Takeda

WORLDWIDE

Talk Title:

HTE & Automation to Accelerate Synthetic Molecules R&D

Abstract:

Brian London_Headshot

Brian London, PhD

Chief Software Engineer

StableBody Tech

WORLDWIDE

Talk Title:

The Impact of BioDesign on BioManufacturing

Abstract:

StableBody Technologies LLC, is revolutionizing the bio-processing industry with their proprietary “Universal Rational Protein BioDesign Using Proprietary Thermodynamic Stabilization of Proteins”. This innovative technology utilizes unique and powerful algorithms to generate amino acid sequences for structurally and functionally improved antibody protein products (Cold Chain Free™). With the introduction of AffiBio-UIA™, scientists have access to this cutting-edge technology, providing greater control over the design process while significantly reducing development and processing time and cost.

Amanda Savidge_Headshot

Amanda Savidge

Senior Account Executive

LabVoice

WORLDWIDE

Talk Title:

The Human Element of Data Entry: Laboratory Orchestration with a Scientist-Centric Approach

Abstract:

You walk into a cell culture laboratory, what do you see? Benches, incubators, PCR cyclers, flasks, bioreactors, pipettes, media…and people. Critically, scientists and technicians will continue to be key to laboratory task execution and their data recording process hasn’t changed in decades. In many cases, observations and data are still recorded on paper notebooks and later transcribed into another digital system (ELN, spreadsheets, etc). LabVoice has created tools to take these scientist-centric lab activities and change where, when, and how data can be recorded. Using a mobile-app based platform, LabVoice uses a number of connected inputs, including voice, to create a novel data entry platform. This presentation will walk you through the capabilities and benefits of a digital laboratory assistant. Hear about how LabVoice can enrich research data to support laboratory insights for process optimization and enable automation that takes direct inputs from the scientists at the bench.

Martin-Immanuel Bittner_Headshot.

Martin-Immanuel Bittner, MD, PhD

Co-Founder & CEO

Arctoris

WORLDWIDE

Talk Title:

Leveraging Wet Lab Automation in Integrated End-to-End Drug Discovery

Abstract:

In this presentation, we will explore the transformative potential of leveraging wet lab automation in drug discovery. Pioneered by companies like Strateos and Arctoris, developing integrated, automated drug discovery processes on demand is a paradigm shift for the biotech and pharma industry.

 

The talk will explore the development and evolution of Strateos’ platform, software, and process capabilities, as well as the development and evolution of Arctoris’ Ulysses platform. The unique potential of integrated wet lab automation will come to life with case studies and practical examples highlighting successful use cases accelerating both small molecule and biologics discovery.

 

Finally, the talk will also present a view towards the future, including current trends, on-going developments, and partnerships on the horizon.

Patrick Courtney Headshot

Patrick Courtney, PhD

Member Board of Directors; Marketing Lead

SiLA

WORLDWIDE

Talk Title:

Interoperability Standards as an Enabler for the Cloud Laboratory

Abstract:

Wei Liu_Headshot

Wei Liu, PhD

Scientist

Johnson & Johnson

WORLDWIDE

Talk Title:

High-Throughput Chemistry to Accelerate Drug Discovery

Abstract:

2022 CLOUD LAB, HTE, & LAB AUTOMATION VIRTUAL CONFERENCE (Year 2)

Conference Recordings

CloudLab LinkedIn Image
Cloud Lab Speakers_2022
Cloud Lab Sponsor Logos_2022

CONFERENCE AGENDA

KEYNOTE

Marc Siladi_Headshot

Marc Siladi

EXECUTIVE DIRECTOR 

Strateos

Tuesday, Nov. 8th at 10 AM EST

 

Beyond Digital: Leveraging Digital Transformation to Scale Impact

Abstract:

In this presentation Strateos will equip the audience with a deeper understanding of the path to automation, while establishing the value of a transformed unit. We will review the new enablers within LodeStar and how they are leveraged to absorb both routine and non-routine lab work. In the end the audience will understand not only the transformation available, but also the scaled impact realized.

Adam Wheeler_Headshot

Adam Wheeler

DIRECTOR OF MARKETING

Strateos

Tuesday, Nov. 8th at 10 AM EST

 

Beyond Digital: Leveraging Digital Transformation to Scale Impact

Abstract:

In this presentation Strateos will equip the audience with a deeper understanding of the path to automation, while establishing the value of a transformed unit. We will review the new enablers within LodeStar and how they are leveraged to absorb both routine and non-routine lab work. In the end the audience will understand not only the transformation available, but also the scaled impact realized.

Stanislav _Elsci

CEO

Stanislav Bashkyrtsev

Elsci Life Sciences

Wednesday, Nov. 9th at 11 AM EST

Modernizing Software Processes in Life Sciences

Abstract:

Life Sciences IT is quite isolated from the rest of the IT world. On the one hand it's pierced by advanced technology like Robotics/AI/ML/HPC; on the other hand lots of scientists still use spreadsheets on a daily basis, and most software looks and feels archaic.

I'd like to speculate on why this is the case and what we can do to improve the situation. We'll talk about:

• Modern software processes, and how they differ from what Big Pharma is doing

• UX, and how high-quality software should look and behave

• How scientists can help IT; and what's required on the IT side

John Walzer_Headshot

John Walzer

SCIENTIFIC ADVISOR

Singh Instruments

Thursday, Nov. 10th at 10 AM EST

 

Successful Implementation of Automated Workflows in Chemistry versus Life Sciences: It's the Little Things

Abstract:

This presentation will investigate the challenges in implementing automated workflows in the Chemistry/Materials space, emphasizing those areas which differ from Life Sciences. We will discuss how the Singh Instruments (SI) approach of developing bespoke automation solutions based on proven industrial automation platforms can enable robust automated workflows with long lifetimes and ongoing support, despite the challenges of harsher reagents and extreme process operating windows. We will also discuss how SI has overcome the natural friction between use of (difficult to program) industrial robotics and the need to have software which is flexible and approachable so that researchers can be actively involved in designing and modifying automated experiments.

Nessa Carson_Headshot

Nessa Carson, P

ASSOCIATE PRINCIPAL SCIENTIST

AstraZeneca

Thursday, Nov. 10th at 1 PM EST

Automate Your Own HTE Workflow

Nikkie Dare_Headshot

Nikki Dare

SOLUTION AREA MANAGER, KATALYST D2D

ACD/Labs

Wednesday, Nov. 9th at 10 AM EST

 

Experiment Design and Automation of Analytical Data Processing and Management in HTE

Abstract:

Automation and high throughput synthesis (more generally referred to as High Throughput Experimentation—HTE), with the help of robotics, has allowed scientists to significantly increase experiment output. This also includes the amount of analytical data that can be collected in shorter periods of time. Current solutions for analytical data processing in HTE require tedious and error prone transfer of data, including experimental designs, between multiple software systems, and manual association of analytical results with experiments. We will present purpose-built HTE software that not only integrates with existing hardware and software to bring all design, planning, and execution into a single interface; it also automates targeted analytical data processing and association of analytical data to experimental design.

Teodor Laino_Headshot

Teodoro Laino

RESEARCH MANAGER

IBM

Wednesday, Nov. 9th at 11:30 AM EST

 

Accelerating Chemistry with Cloud-based AI Driven Autonomous Labs

Teodoro Laino, Matteo Manica, Alain Claude Vaucher, Aleksandros Sobczyk, Amol Thakkar, Carlo Baldassari, Artem Leonov, Alessandra Toniato, Heiko Wolf, Federico Zipoli IBM Research Europe, CH-8803 Rüschlikon, Switzerland teo@zurich.ibm.com

 

 

Abstract:

One of the greatest contributions of chemistry is the ability to create and design new molecules. The synthesis of many novel molecular structures has relied heavily on the application of domain knowledge acquired over many years of laboratory work. But most synthetic success stories are preceded by long hours of unproductive repetitive experiments. The development of automation systems within the last two decades to help chemists with mundane laboratory tasks has contributed to the mitigation of this issue. There are some areas, like high-throughput chemistry, where these technologies have proven to be particularly useful, but automating general-purpose jobs is still a very difficult problem to solve. Operators in the chemical industry must create specialized software for each operation, with the goal of codifying a particular chemical process. Meanwhile, Artificial Intelligence (AI) has established itself as a valuable complement to human knowledge and creativity in organic chemistry, performing tasks such as predicting chemical reactions [1-2], retrosynthetic routes [3], digitizing chemical literature [4], and predicting experimental procedures for previously unseen chemistry [5]. In this talk, I'll talk about the lessons learned and the opportunities of a fully autonomous laboratory run by artificial intelligence and accessible through the cloud [6].

 

•[1] IBM Research Europe, Chem. Sci., 2018, 9, 6091-6098

•[2] IBM Research Europe, ACS Cent. Sci. 2019, 5, 9, 1572-1583

•[3] IBM Research Europe, Chem. Sci., 2020, 11, 3316-3325

•[4] IBM Research Europe, Nat. Comm., 11, 2601 (2020)

•[5] IBM Research Europe, Nat. Comm., 12, 2573 (2021) [6] https://rxn.res.ibm.com

Ralf Sonnefeld_Headshot

Ralf Sonnefeld

EVP

Xavo Software, AG

Thursday, Nov. 10th at 11:30 AM EST

How to deliver samples ‘at the speed of science’ with cloud-native Sample Management Software

Abstract:

Biopharma R&D is changing rapidly: trends like High-Throughput Experimentation, Multi-Omics, Microbiome, Dynamic Assay Cascades, and growing Biorepositories dramatically change the way samples of R&D materials need to be provided in the context of projects and studies. The only way to keep up with these trends and resulting challenges is to make use of the power of a truly cloud-native Sample Management Software system. We will present how such a system, Xavo R3, is used today to increase agility and throughput in the lab while also providing higher flexibility in the integration with Lab Equipment and 3rd party IT systems.

Mark Kalinich_Headshot

Mark Kalinich, MD, PhD

CO-FOUNDER, CSO

Watershed Informatics

Tuesday, Nov. 8th at 1 PM EST

Next-Generation Multi-Omics Compute & Analysis Platform at a Fraction of Today’s Typical Operational Cost!

Eugenie Romero_Headshot

Eugénie Romero

MANAGER - HTE CENTER

French Atomic Energy Commission

Wednesday, Nov. 9th at 1:30 PM EST

 

High-Throughput Experimentation: Between Innovation and Accessibility

Abstract:

For years, High-Throughput Experimentation (HTE) has been applied to organic chemistry for reaction optimization and reaction discovery as a powerful tool for time and cost reduction. Suppose this technology has been first developed by and for industry and used as a routine method today. In that case, some academic researchers, including those in Europe, still face the accessibility of HTE as a general and daily used technology. The main reason is probably the expensive cost of such facilities set-up, which generally involves automation with robots, dedicated research teams, and costly analytical instrumentation. It is now the challenge of the HTE practitioners to help scientists implement this valuable methodology in their research programs and highlight the accessibility of HTE with a minimum of instrumentation and cost to enable the highest number of organic chemists to accelerate their research.

Beyond Digital: Leveraging Digital Transformation to Scale Impact

 

Abstract:

In this presentation Strateos will equip the audience with a deeper understanding of the path to automation, while establishing the value of a transformed unit. We will review the new enablers within LodeStar and how they are leveraged to absorb both routine and non-routine lab work. In the end the audience will understand not only the transformation available, but also the scaled impact realized.

Successful Implementation of Automated Workflows in Chemistry versus Life Sciences: It's the Little Things

Juanma D._ Headshot

Juan Manuel Dominguez, PhD

HEAD OF DRUG DISCOVERY

Topazium

Tuesday, Nov. 8th at 11:30 AM EST

Harnessing the Power Of HTE, Cloud Labs, and Lab Automation-Generated Data to Transform Drug Discovery Using Artificial Intelligence

Abstract:

Drug discovery is a lengthy and costly process affected by a high attrition rate. The revolution in experimental sciences brought about by HTE, cloud labs and lab automation should represent an excellent opportunity to completely transform drug discovery and overcome the serious problems that hinder the process. But this transformation will not be possible without the right tools to harness the valuable information hidden in the profusion of data generated by these new disciplines. Artificial intelligence (AI), and its multiple applications, are the key to achieve such a challenging goal and many companies are now using AI to improve the performance of every step of the drug discovery process. Topazium is a startup company fully committed to creating a new collective intelligence that enables wiser medicine and, in this context, has developed new tools to improve drug discovery performance based on a novel, circular paradigm for the process. Such a paradigm leverages the value of the information generated at each stage to feed the others, regardless of their relative position in the cycle. This presentation will summarize the concepts underlying this cyclical process and present some of the AI tools developed at Topazium that will contribute to the necessary disruption in drug discovery.

Phil Eschallier Heashot

Phil Eschallier

CHIEF TECHNOLOGY OFFICER

RCH Solutions

Tuesday, Nov. 8th at 1:30 PM EST

Abstract: 

In an industry driven by the pursuit of progress, the ability for biopharma teams to fully harness innovation and technology to support discovery has long been a differentiator. Today, as new and emerging technologies transform expectations for how the business of science is accomplished, more teams are turning to the Cloud as part of their modernization strategy and push to create a scalable, extensible next generation compute environment.

 

What Attendees Will Learn: 

In this case study focused presentation, RCH’s CTO, Phil Eschallier, will share real-life examples of how R&D teams and their Bio-IT counterparts are building future-forward Cloud-first compute environments that will help them accelerate time to discovery and lead to more successful outcomes today—and tomorrow.

Joe Pulawski_Headshot

Joe Pulawski

SENIOR ACCOUNT MANAGER

Hudson Robotics

Thursday, Nov. 10th at 1:30 PM EST

Accelerating Life Science Through Automation

TJ Murphy Headshot LabVoice

TJ Murphy

SALES EXECUTIVE

LabVoice

Thursday, Nov. 10th at 10:30 AM EST

Laboratory Digital Assistants: A Look at Some Common Use Cases

Martin-Immanuel Bittner_Headshot

Martin-Immanuel Bittner

Co-Founder & CEO

Arctoris

Tuesday, Nov. 8th at 11:00 AM EST

Combining robotics and machine learning in drug discovery

Abstract

The talk will cover how recent advances in wet lab automation and artificial intelligence/ machine learning enable a paradigm shift in drug discovery. Martin-Immanuel Bittner MD DPhil FRSA FRSB FIBMS, Co-Founder & CEO of Arctoris, will address the changing landscape of drug discovery, discussing how combining robotics and machine learning transforms the drug discovery process. The critical role of data quality and data capture will be explored, looking both at general industry trends as well as concrete case studies. Using Arctoris as an example, the talk will describe how a fully automated research platform can enable researchers to focus on experiment planning and data analysis, with experiment execution delegated to advanced robotics - improving data and decision-making in research processes, and allowing for programs to move from idea to IND faster and more efficiently.

Adam Paton_Headshot

Adam Paton

Principal Client Partner

Zifo RnD Solutions 

Wednesday, Nov. 9th at 10:30 AM EST

Michael Norman_Headshot

Michael Norman

GM & VP of Sales - North America

Flow Robotics

Thursday, Nov. 10th at 11:00 AM EST

Automate, Don’t Irritate

Abstract: 

With the landscape of today’s lab, connecting scientists running manual methods to automation engineers building out full scale automated labs has traditionally not been a clear path in the automated liquid handling space.  Complexities in understanding the science as well as programming languages hasn’t been geared towards adoption amongst sciences until now.

Ash Jogalekar_Headshot

Ash Jogalekar

Head of Product

OpenEye Scientific

Tuesday, Nov. 8th at 10:30 AM EST

Drug Design in the Cloud: It Keeps Getting Better

Abstract: </